New Product Process Review: How Firms Can Launch with Better Controls
Subscribe to our original industry insights
Launching a new investment product is one of the highest-risk activities a broker-dealer or registered investment advisor (RIA) can undertake. Without a structured new product process review, firms expose themselves to regulatory scrutiny, operational failures, and suitability gaps that can surface long after a product is already in clients’ hands. A disciplined, cross-functional review process is not just a best practice, it is a regulatory expectation.
What Is a New Product Process Review?
A new product process review is a structured, pre-launch evaluation that assesses whether a firm has the compliance, supervisory, operational, and sales infrastructure in place to support a new investment product. It is designed to identify risks before they become problems.
The review typically involves stakeholders from compliance, legal, operations, technology, and the business line. Together, they evaluate the product’s structure, the firm’s readiness to supervise it, and whether existing controls are sufficient or whether new ones must be built.
FINRA has long emphasized the importance of this process. Regulatory Notice 05-26 outlined expectations for firms to conduct due diligence on new products, and Notice 12-03 reinforced the need for robust product review frameworks, particularly for complex or structured products. More recently, Notice 22-08 addressed the risks associated with emerging product types and reminded firms that supervisory obligations apply regardless of how novel the product may be.
Why Does Product Governance Matter Before Launch?
Strong product governance before launch prevents costly remediation after the fact. Firms that skip or rush the review process often discover during an exam or after a customer complaint that their supervisory procedures did not account for the product’s unique risks, their registered representatives were not adequately trained, or their operational systems could not support accurate reporting.
The consequences are significant. Regulatory sanctions, restitution orders, and reputational damage are all possible outcomes when product governance breaks down. A proactive new product approval process is far less expensive than a reactive one.
Steps for an Effective New Product Review Process
Step 1: Assess the Product
The first step in any new product process review is a thorough assessment of the product itself including its structure, risk profile, liquidity characteristics, and target investor population.
Key questions to answer at this stage include:
- What type of product is it: a structured note, alternative investment, private placement, or something else?
- Who is the intended investor, and what suitability criteria apply?
- What are the liquidity terms, and how do they affect investor expectations?
- Are there concentration limits or other restrictions that must be built into supervision?
- Does the product involve any third-party managers, issuers, or platforms that require additional due diligence?
This assessment forms the foundation for every subsequent step. Without a clear understanding of what the product is and how it behaves, it is impossible to build appropriate controls around it.
Step 2: Review the Risks
Once the product is understood, the next step is a formal risk assessment which includes a gap analysis that compares the product’s risk profile against the firm’s existing supervisory and operational capabilities.
This gap analysis should evaluate:
- Regulatory risk: Does the product trigger any specific FINRA, SEC, or state-level requirements? Are there disclosure obligations, concentration limits, or suitability standards that go beyond the firm’s standard framework?
- Supervisory risk: Do existing written supervisory procedures (WSPs) cover this product type? If not, new procedures must be drafted and approved before launch.
- Operational risk: Can the firm’s back-office systems accurately process, report, and reconcile this product? Are there settlement, custody, or reporting requirements that require system changes?
- Sales and training risk: Do registered representatives understand the product well enough to make suitable recommendations? Is additional training required before they are permitted to sell?
A thorough gap analysis at this stage prevents the firm from discovering these deficiencies mid-launch, or worse, during a regulatory examination.
For firms with active trading operations, a Trade Desk Review can complement the product review process by evaluating whether trading infrastructure and best execution practices are aligned with the new product’s requirements.
Step 3: Build the Approval Framework
With risks identified, the firm must build or update its new product approval process to reflect the findings. This is where cross-functional collaboration is most critical.
The approval framework should include:
- A formal sign-off process that requires documented approval from compliance, legal, operations, and senior management before any product is offered to clients.
- Updated WSPs that specifically address the new product, including supervision of recommendations, concentration monitoring, and complaint handling.
- A training plan for all registered representatives who will sell the product, with documented completion records.
- A disclosure review to ensure all marketing materials, term sheets, and client-facing documents meet regulatory standards.
- A technology and systems checklist confirming that all operational requirements have been met.
This framework should be documented and retained as part of the firm’s supervisory records. Regulators expect to see evidence that the approval process was followed and not just that it exists on paper.
Step 4: Build Post-Launch Oversight
A new product process review does not end at launch. Post-launch oversight is an essential component of investment product compliance and should be built into the approval framework from the start.
Post-launch controls should include:
- Ongoing suitability monitoring to identify any patterns of unsuitable recommendations
- Periodic reviews of concentration levels across client accounts
- A defined escalation process for complaints or unusual activity related to the product
- Scheduled reviews of the product’s performance and risk profile against original assumptions
- Regular updates to WSPs and training materials as the product evolves or regulatory guidance changes
Sales supervision is particularly important in the post-launch phase. Firms should establish clear metrics for monitoring sales activity and ensure that supervisory principals are reviewing transactions on a regular basis.
For broader compliance support across your broker-dealer or RIA, Oyster’s BD/RIA Compliance Support services provide the infrastructure and expertise to maintain ongoing oversight across all product lines.
Who Should Be Involved in the Review Process?
Effective new product reviews require input from multiple stakeholders not just compliance. Each function brings a distinct perspective that is essential to a complete assessment.
- Compliance and Legal: Regulatory analysis, WSP development, disclosure review
- Operations: Systems readiness, settlement, reporting, and reconciliation
- Technology: Platform compatibility, data integrity, and reporting infrastructure
- Business/Sales Leadership: Product rationale, target market, and sales strategy
- Senior Management: Final approval authority and accountability
When these groups work together through a structured process, the result is a product launch that is not only compliant but operationally sound and commercially viable.
Frequently Asked Questions
What is the purpose of a new product process review?
A new product process review evaluates whether a firm has the compliance, supervisory, and operational infrastructure in place to support a new investment product before it is offered to clients. The goal is to identify and remediate gaps before launch, reducing regulatory and operational risk.
What is included in a new product approval process?
A new product approval process typically includes a product assessment, a gap analysis of existing controls, updates to written supervisory procedures, a training plan for registered representatives, a disclosure review, and documented sign-off from compliance, legal, operations, and senior management.
What FINRA guidance applies to new product reviews?
FINRA Regulatory Notice 05-26 (https://www.finra.org/rules-guidance/notices/05-26) established foundational expectations for new product due diligence. Notice 12-03 (https://www.finra.org/rules-guidance/notices/12-03) reinforced the need for robust product review frameworks for complex products. Notice 22-08 (https://www.finra.org/rules-guidance/notices/22-08) addressed emerging product types and reiterated that supervisory obligations apply to all new products regardless of novelty.
How does a gap analysis support product governance?
A gap analysis compares a new product’s risk profile against the firm’s existing supervisory and operational capabilities. It identifies where current procedures, systems, or training fall short and what must be built or updated before the product can be safely launched.
What happens if a firm skips the new product review process?
Firms that bypass a structured review process risk launching products without adequate supervisory procedures, untrained representatives, or unsupported operational systems. These gaps can result in regulatory sanctions, customer complaints, restitution orders, and reputational damage.
Launch with Confidence: How Oyster Can Help
A structured new product process review is one of the most effective risk management tools available to broker-dealers and RIAs. It brings discipline to the launch process, aligns stakeholders around a common framework, and gives regulators the evidence they need to see that your firm takes product governance seriously.
Oyster’s New Products Process Review service is designed to help firms build and execute this process from the ground up or strengthen an existing framework that may have gaps. Our team of industry professionals brings decades of hands-on experience in compliance, operations, and capital markets to every engagement.
If your firm is preparing to launch a new investment product and wants to ensure every control is in place before you go to market, we are ready to help. Contact Oyster today to discuss your product review needs and launch with greater regulatory confidence.
Contact Oyster today to learn more about how we can support your new product review process.
